Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Fruquintinib. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN112724110B details a novel nickel-catalyzed route for VEGFR inhibitor intermediates, offering significant cost reduction and scalability for pharmaceutical manufacturing.